Venture-Backed Startups

Emproof develops security solutions for embedded systems, providing lightweight external protection against cyberattacks for connected devices. The company serves manufacturers and developers across industries requiring embedded system security.

1 investor

0 investors

Emprunte mon Toutou is a French online platform connecting pet owners with volunteer borrowers who walk or look after their dogs, cats and other animals for free, whether for short outings, a few hours, or weekend care. Operating since 2017, it serves pet owners and animal lovers across France as a peer-to-peer pet care community.

1 investor

Emptor provides a background-check and credential-verification platform for recruitment and onboarding teams, using an intelligent virtual assistant called Sol to verify credentials and references. It serves companies hiring across Latin America and integrates with tools like Greenhouse to support high-volume, compliant hiring.

1 investor

3 investors

0 investors

1 investor

Empyrean Solutions provides integrated treasury, FP&A, and analytics software for banks and credit unions, covering asset-liability management, budgeting and planning, and profitability measurement. Its tools run on a unified data platform that connects risk and performance data for financial institutions of all sizes.

1 investor

EMQ operates a global payments network with last-mile endpoints that banks can integrate to enable cross-border money transfers and automate payment processes. It targets banks and financial institutions seeking to add digital money transfer services to their networks and mobile apps.

3 investors

EMQX provides high-performance data movement, processing, and integration infrastructure for Internet of Things applications in business-critical environments.

1 investor

0 investors

Digital solutions for efficient capital market operations and security issuances

1 investor

0 investors

EMS SOAP is an AI platform that generates protocol-compliant patient care narratives for emergency medical services, reducing paperwork time and insurance claim denials. It serves EMS agencies across the United States, learning each agency's local medical protocols to support documentation quality and transport reimbursement.

1 investor

0 investors

0 investors

EMSU operates a retail media platform that connects brands and retailers through touchpoint advertising directly at products. The platform enables brands to launch advertising campaigns and retailers to monetize their physical retail spaces, with the stated goal of increasing sales up to 300%.

1 investor

EMTECH builds software for central banks and regulated financial institutions to run digital regulatory sandboxes, central bank digital currency (CBDC) systems, compliance and supervision tools, e-wallets, and APIs. Its "Beyond Suite" products serve regulators and financial market infrastructure, with adoption among central banks in Africa and the Caribbean.

4 investors

Emteq Labs develops wearable technology that monitors and translates facial expressions to measure emotional and behavioral responses in real-world settings. The company's OCOsense platform uses contact-free sensors to detect facial muscle activity and biometric data for applications across health, research, and consumer industries.

1 investor

emteria provides a platform and tools for building, customizing, and managing custom Android-based operating systems across thousands of devices. It targets product builders and industrial/professional use cases, offering OS customization, full device software control, and over-the-air update management with long-term support.

1 investor

Emtethal builds a monitoring system for hospitality operators that combines computer vision with IoT sensors. It flags food safety and operational violations as they occur, helping restaurants and similar businesses correct issues before regulatory inspections result in penalties.

1 investor

Emtherapro develops biomarkers and therapies for neurodegenerative diseases, including Alzheimer's disease, using proteomics-based methods. It partners with researchers, biotech and pharmaceutical companies, and healthcare organizations to create new diagnostics and therapies.

0 investors

Emtora Biosciences is a clinical-stage life science company developing eRapa, a novel formulation of rapamycin, to prevent the onset and recurrence of cancer. Its lead program, Serenta (eRapa), is in a Phase 3 trial evaluating safety and efficacy in patients diagnosed with familial adenomatous polyposis (FAP).

1 investor

emTRUTH provides a blockchain-based healthcare data management platform that enables secure, encrypted data aggregation and sharing across healthcare systems. The solution integrates with leading electronic health record systems and supports standard healthcare data formats for healthcare organizations and public health partners.

1 investor